UK gets £100m stem cell boost
By The Register,
The Register
| 12. 02. 2005
The UK's stem cell research programmes will benefit from £100m over the next two years after Gordon Brown doubled the government's financial committement to the technology, Reuters reports. Brown said the cash would go to "pre-commercial aspects of stem cell research" - considered high-risk by pharmaceutical companies - and the recently-established UK Stem Cell Foundation.
More specifically, the money was destined for "clinical trials within the state health service, research into cell production facilities" and support for the UK's stem cell bank.
Brown said at an enterprise conference in London: "Britain should be the world's number one centre for genetic and stem cell research, building on our world leading regulatory regime in the area."
The UK has already adopted a rigourous pro-research stance in the face of widespread opposition to the technology. Back in March, it declared it would ignore a non-binding UN ban on human cloning, at least as far as therapeutic cloning is concerned. Health secretary John Reid noted: "Reproductive cloning is already illegal in the UK. Anyone attempting it in this country faces a 10-year prison sentence...
Related Articles
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Ed Pilkington, The Guardian | 06.12.2026
Desperate US parents paying up to $20,000 a session for a procedure scientists say could be bogus
Autistic children as young as 18 months old are being injected with human stem cells derived from umbilical cords in unapproved, unproven and...
By Tobi Thomas, The Guardian | 06.10.2026
The UK’s stem cell transplant system is potentially putting the lives of blood cancer patients at risk as a result of inadequate infrastructure and a lack of long-term planning, a parliamentary report has found.
A hematopoietic stem cell transplant, often...